Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of amiloride and spironolactone on renal and cardiovascular parameters in hypertension
2010-020599-47Phase 4Completed
- Sponsor
- Department of Medical Research
- Start
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of amiloride and spironolactone in hypertension (HTN) and essential hypertension, sponsored by Department of Medical Research. Primary endpoints: Effect of amiloride and spironolactone on blood pressure and Effect of amiloride and spironolactone on renal function and kidney water channels. Started May 2010; status: completed.
02
Drugs
amiloridespironolactone
03
Conditions
hypertension (HTN)essential hypertension
Beyond the preview
Go deeper on 2010-020599-47.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020599-47.